Role of PIR-B in autoimmune glomerulonephritis

27Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

PIR-B, an inhibitory receptor expressed on murine B cells and myeloid cells, regulates humoral and cellular immune responses via its constitutive binding to the ligand, MHC class I molecules, on the same cells (cis) or on different cells (trans). Although it has been speculated that PIR-B is important for maintaining peripheral tolerance, PIR-B single deficiency does not cause overt autoimmune diseases. Recently, however, the combination of its deficiency with the Fas lpr mutation was found to result in augmented production of autoantibodies such as IgG rheumatoid factor and anti-DNA IgG, leading to glomerulonephritis in mice. Although the precise molecular mechanism for the overall scenario is unclear, PIR-B was found to suppress TLR9-mediated production of naturally autoreactive antibodies by innate B cells or B-1 cells by inhibiting the activation of Bruton's tyrosine kinase. Thus, PIR-B is an important regulator of innate immunity mediated by TLR9 in B-1 cells, which can otherwise provoke autoimmunity when overactivated. Copyright © 2011 Toshiyuki Takai et al.

Cite

CITATION STYLE

APA

Takai, T., Nakamura, A., & Endo, S. (2011). Role of PIR-B in autoimmune glomerulonephritis. Journal of Biomedicine and Biotechnology. https://doi.org/10.1155/2011/275302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free